US20110223608A1 - Molecular detection and quantification of enterococci - Google Patents
Molecular detection and quantification of enterococci Download PDFInfo
- Publication number
- US20110223608A1 US20110223608A1 US13/089,146 US201113089146A US2011223608A1 US 20110223608 A1 US20110223608 A1 US 20110223608A1 US 201113089146 A US201113089146 A US 201113089146A US 2011223608 A1 US2011223608 A1 US 2011223608A1
- Authority
- US
- United States
- Prior art keywords
- enterococci
- nasba
- quantification
- primer
- assay
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000001514 detection method Methods 0.000 title description 6
- 238000011002 quantification Methods 0.000 title description 5
- 239000000523 sample Substances 0.000 claims abstract description 14
- 230000003321 amplification Effects 0.000 claims abstract description 12
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 12
- 238000000034 method Methods 0.000 claims description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 claims 1
- 238000003556 assay Methods 0.000 abstract description 9
- 108700022487 rRNA Genes Proteins 0.000 abstract description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract description 2
- 150000007523 nucleic acids Chemical group 0.000 abstract description 2
- 230000002550 fecal effect Effects 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 238000005374 membrane filtration Methods 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 3
- 239000003643 water by type Substances 0.000 description 3
- 241000194033 Enterococcus Species 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003653 coastal water Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 230000037452 priming Effects 0.000 description 2
- 238000012502 risk assessment Methods 0.000 description 2
- 239000013535 sea water Substances 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 1
- 241001468179 Enterococcus avium Species 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 241000194031 Enterococcus faecium Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 108091061960 Naked DNA Proteins 0.000 description 1
- 238000002944 PCR assay Methods 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940032049 enterococcus faecalis Drugs 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 108020004418 ribosomal RNA Proteins 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
Definitions
- This invention relates to rapid detection of an organism, specifically, this is a method for detecting and quantifying Enterococci (a human fecal indicator organism) from sea water.
- NASBA real-time nucleic acid sequence based amplification
- NASBA is able to amplify RNA in a DNA background, and thus, only viable targets will be detected. This is important for indicator monitoring because only recent pollution events will be detected and false positive amplifications of naked DNA present in the sample will be eliminated.
- Indicator bacteria are chosen because of their ability to survive longer than the pathogenic organisms in question and therefore only viable bacteria should be considered as part of a risk analysis.
- Enterococci is the USEPA approved indicator organism used to monitor for fecal pollution in saline waters.
- Current methods rely on membrane filtration and even though the direct enumeration of these microorganisms using membrane filtration and plating has been available for years, there continue to be outbreaks associated with fecal contamination.
- the problem is that there is a lag of at least 24-48 hours between when the sample is collected and when the data become available. Changes in the water quality and potential exposures during this delay lead to management decisions and public notifications that are often times moot.
- To improve management abilities there is a need for rapid detection and quantification of appropriate bacterial indicators in coastal waters and sediments to ensure the safety of these resources for their multiple users.
- the present NASBA based method addresses this issue by quantitatively amplifying the target RNA and providing results in less than one hour.
- the FIGURE shows sequences for primers and probe for NASBA amplification of Enterococci.
- NASBA primers and probes were designed based on homologous regions of the large subunit ribosomal RNA gene (The FIGURE). This region is highly conserved within all reported species of the Enterococcus genus (Haugland et al., 2005). Previous researchers (Frahm and Obst, 2003) used this region as the priming site for the development of a Taqman PCR assay for enterococci detection.
- the primers have been modified to best fit the NASBA amplification requirements and molecular beacon design criteria as well as minimize the cross hybridization to each other.
- This primer set has been tested against Enterococcus faecalis and E. faecium, and E. avium, as well as several other genera of Gram positive and Gram negative bacteria to determine the specificity of the assay and ensure that no cross reactivity occurs to non-target organisms. Data thus far indicate that the primer set is specific to the genus enterococci.
- the assay sensitivity has been evaluated using serially diluted RNA isolated from enterococci cells. It is also possible to include cell extract samples from individual species as well as mixtures of all of the enterococci species available. Because ribosomal RNA tends to have a complex secondary structure, the NASBA assay was initiated by a 65° C. denaturing step for 3 minutes prior to the 41° C. amplification step (60 to 90 minutes). This initial denaturation is required for some, but not all NASBA assays and its requirement for efficient amplification of enterococci still needs to be evaluated.
- Amplification inhibitors are often co-purified with natural environmental samples. These inhibitors have been encountered in coastal water filtrates (Casper et al., 2005b). However, this inhibition tends to occur in sample volumes greater than 200 ml. For enterococci samples, the sample volume will always be less than 100 ml (as used by the DOH). Also, an internal control (IC-NASBA protocol) is included that will be used to normalize the amplification results (Patterson et al., 2005). This approach will increase the precision of our quantification and reduce the amount of false negative results. Because the internal control molecule contains the same priming site as the target, the amplification reaction becomes competitive. Serial titrations of internal control RNA determine the optimal concentration to allow for consistent quantification of enterococci within the expected environmental concentrations (Patterson et al., 2005).
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
A primer pair and probe for the large subunit ribosomal RNA gene of enterococci for use in a real-time nucleic acid sequence based amplification (NASBA) assay.
Description
- This application is a continuation of U.S. patent application Ser. No. 11/735,618, filed Apr. 16, 2007, which claims the benefit of U.S. Provisional Patent Application 60/744,850, filed Apr. 14, 2006, the contents of each of which are herein incorporated by reference.
- This invention was made with Government support under Grant No. 25000 172 00 awarded by the National Science Foundation. The government has certain rights in the invention.
- This invention relates to rapid detection of an organism, specifically, this is a method for detecting and quantifying Enterococci (a human fecal indicator organism) from sea water.
- The coastal ocean is an important economic and recreational resource that is constantly influenced by human activities. In 2003, there were more than 18,000 days of beach closings throughout the US due to high concentrations of fecal bacteria. This was an increase of more than 51% over the previous year. Health related management of recreational coastal sites is currently undertaken by monitoring fecal coliform and enterococci by membrane filtration. Elevated concentrations of enterococci in marine waters have been shown to have a strong correlation with illness (especially gastrointestinal disease) in exposed individuals therefore making enterococci the indicator organism of choice for saline waters. The problem with this type of standard indicator monitoring is that there is a lag of at least 24-48 hours between when the sample is collected and when the data become available. Changes in the water quality and potential exposures during this delay lead to management decisions and public notifications that are often times inaccurate. To improve our management abilities, a primer pair and probe have been adapted for the large subunit ribosomal RNA gene of enterococci for use in a real-time nucleic acid sequence based amplification (NASBA) assay. This region is highly conserved within all reported species of the Enterococcus genus. Using this assay, the equivalent of less than one enterococci colony forming unit (CFU) was detected from a spiked sea water sample (100 ml). Further, there is a negative linear relationship (R2=0.9484) between CFUs obtained by membrane filtration and time to positivity (TTP) readings obtained with the NASBA assay. Therefore, quantitative estimates of enterococci are possible over at least four orders of magnitude and all positive samples amplified within forty-three minutes. By coupling this real-time NASBA assay to the inventor's existing field RNA extraction procedure and portable NASBA detection device, this technology will provide a simple, rapid (<1 hr), convenient testing format for coastal sites and greatly improve the health risk assessment of these regions.
- Unlike polymerase chain reaction (PCR) based methods, NASBA is able to amplify RNA in a DNA background, and thus, only viable targets will be detected. This is important for indicator monitoring because only recent pollution events will be detected and false positive amplifications of naked DNA present in the sample will be eliminated. Indicator bacteria are chosen because of their ability to survive longer than the pathogenic organisms in question and therefore only viable bacteria should be considered as part of a risk analysis.
- This is a method for the detection and quantification of Enterococci. Enterococci is the USEPA approved indicator organism used to monitor for fecal pollution in saline waters. Current methods rely on membrane filtration and even though the direct enumeration of these microorganisms using membrane filtration and plating has been available for years, there continue to be outbreaks associated with fecal contamination. The problem is that there is a lag of at least 24-48 hours between when the sample is collected and when the data become available. Changes in the water quality and potential exposures during this delay lead to management decisions and public notifications that are often times moot. To improve management abilities, there is a need for rapid detection and quantification of appropriate bacterial indicators in coastal waters and sediments to ensure the safety of these resources for their multiple users. The present NASBA based method addresses this issue by quantitatively amplifying the target RNA and providing results in less than one hour.
- For a fuller understanding of the invention, reference should be made to the following detailed description, taken in connection with the accompanying drawings, in which:
- The FIGURE shows sequences for primers and probe for NASBA amplification of Enterococci.
- NASBA primers and probes were designed based on homologous regions of the large subunit ribosomal RNA gene (The FIGURE). This region is highly conserved within all reported species of the Enterococcus genus (Haugland et al., 2005). Previous researchers (Frahm and Obst, 2003) used this region as the priming site for the development of a Taqman PCR assay for enterococci detection. The primers have been modified to best fit the NASBA amplification requirements and molecular beacon design criteria as well as minimize the cross hybridization to each other. This primer set has been tested against Enterococcus faecalis and E. faecium, and E. avium, as well as several other genera of Gram positive and Gram negative bacteria to determine the specificity of the assay and ensure that no cross reactivity occurs to non-target organisms. Data thus far indicate that the primer set is specific to the genus enterococci.
- The assay sensitivity has been evaluated using serially diluted RNA isolated from enterococci cells. It is also possible to include cell extract samples from individual species as well as mixtures of all of the enterococci species available. Because ribosomal RNA tends to have a complex secondary structure, the NASBA assay was initiated by a 65° C. denaturing step for 3 minutes prior to the 41° C. amplification step (60 to 90 minutes). This initial denaturation is required for some, but not all NASBA assays and its requirement for efficient amplification of enterococci still needs to be evaluated.
- Amplification inhibitors are often co-purified with natural environmental samples. These inhibitors have been encountered in coastal water filtrates (Casper et al., 2005b). However, this inhibition tends to occur in sample volumes greater than 200 ml. For enterococci samples, the sample volume will always be less than 100 ml (as used by the DOH). Also, an internal control (IC-NASBA protocol) is included that will be used to normalize the amplification results (Patterson et al., 2005). This approach will increase the precision of our quantification and reduce the amount of false negative results. Because the internal control molecule contains the same priming site as the target, the amplification reaction becomes competitive. Serial titrations of internal control RNA determine the optimal concentration to allow for consistent quantification of enterococci within the expected environmental concentrations (Patterson et al., 2005).
- The following citations are incorporated herein by reference:
- Haugland R. A., Siefring S. C., Wymer L. J., Brenner K. P., Dufour A. P. 2005. Comparison of Enterococcus measurements in freshwater at two recreational beaches by quantitative polymerase chain reaction and membrane filter culture analysis. Water Res.39(4):559-68.
- Frahm E, Obst U. 2003. Application of the fluorogenic probe technique (TaqMan PCR) to the detection of Enterococcus spp. And Escherichia coli in water samples. J Microb Meth 52: 123-131.
- It will be seen that the advantages set forth above, and those made apparent from the foregoing description, are efficiently attained and since certain changes may be made in the above construction without departing from the scope of the invention, it is intended that all matters contained in the foregoing description or shown in the accompanying drawings shall be interpreted as illustrative and not in a limiting sense.
- It is also to be understood that the following claims are intended to cover all of the generic and specific features of the invention herein described, and all statements of the scope of the invention which, as a matter of language, might be said to fall there between. Now that the invention has been described,
Claims (3)
1. A method for quantifying Enterococci in a sample of saline water, said method comprising: performing NASBA amplification, wherein said amplifying step comprises contacting said sample with a pair of primers to produce an amplification product, wherein said pair of primers comprises a first primer and a second primer, wherein said first primer comprises SEQ ID NO:1, and said second primer comprises SEQ ID NO: 2.
2. The method of claim 1 wherein said second primer includes a T7 promoter region comprising SEQ ID NO: 3.
3. The method of claim 1 further comprising a probe, said probe comprising SEQ ID NO: 4.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/089,146 US20110223608A1 (en) | 2006-04-14 | 2011-04-18 | Molecular detection and quantification of enterococci |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74485006P | 2006-04-14 | 2006-04-14 | |
| US11/735,618 US7947441B2 (en) | 2006-04-14 | 2007-04-16 | Molecular detection and quantification of Enterococci |
| US13/089,146 US20110223608A1 (en) | 2006-04-14 | 2011-04-18 | Molecular detection and quantification of enterococci |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/735,618 Continuation US7947441B2 (en) | 2006-04-14 | 2007-04-16 | Molecular detection and quantification of Enterococci |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20110223608A1 true US20110223608A1 (en) | 2011-09-15 |
Family
ID=38610231
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/735,618 Expired - Fee Related US7947441B2 (en) | 2006-04-14 | 2007-04-16 | Molecular detection and quantification of Enterococci |
| US13/089,146 Abandoned US20110223608A1 (en) | 2006-04-14 | 2011-04-18 | Molecular detection and quantification of enterococci |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/735,618 Expired - Fee Related US7947441B2 (en) | 2006-04-14 | 2007-04-16 | Molecular detection and quantification of Enterococci |
Country Status (2)
| Country | Link |
|---|---|
| US (2) | US7947441B2 (en) |
| WO (1) | WO2007120869A2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2626481T3 (en) * | 2011-09-28 | 2017-07-25 | Lonza Walkersville, Inc. | Molecular targets and methods for formulation screening and preservative efficacy testing |
Citations (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4851330A (en) * | 1983-01-10 | 1989-07-25 | Kohne David E | Method for detection, identification and quantitation of non-viral organisms |
| US5334501A (en) * | 1989-07-11 | 1994-08-02 | Microprobe Corporation | Quantification of bacteria using a nucleic acid hybridization assay |
| US5409818A (en) * | 1988-02-24 | 1995-04-25 | Cangene Corporation | Nucleic acid amplification process |
| US5650290A (en) * | 1994-04-01 | 1997-07-22 | Hach Company | Method & Medium for use in detecting E. coli and total coliforms |
| US5695946A (en) * | 1991-02-14 | 1997-12-09 | Vicam, Lp | Assay method for detecting presence of bacteria |
| US5723597A (en) * | 1983-01-10 | 1998-03-03 | Gen-Probe Incorporated | Ribosomal nucleic acid probes for detecting organisms or groups of organisms |
| US6001564A (en) * | 1994-09-12 | 1999-12-14 | Infectio Diagnostic, Inc. | Species specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
| US6355421B1 (en) * | 1997-10-27 | 2002-03-12 | Boston Probes, Inc. | Methods, kits and compositions pertaining to PNA molecular beacons |
| US6583275B1 (en) * | 1997-07-02 | 2003-06-24 | Genome Therapeutics Corporation | Nucleic acid sequences and expression system relating to Enterococcus faecium for diagnostics and therapeutics |
| US6821770B1 (en) * | 1999-05-03 | 2004-11-23 | Gen-Probe Incorporated | Polynucleotide matrix-based method of identifying microorganisms |
| US7025112B1 (en) * | 2004-12-15 | 2006-04-11 | The United States Of America As Represented By The Secretary Of The Navy | Pretreatment processing of metal-matrix carbide power for mold casting of products |
| US7118870B2 (en) * | 2001-09-28 | 2006-10-10 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Detection of fecal contamination using nucleic acid molecules that recognize bacterial 16S rDNA sequences |
| US7422857B2 (en) * | 2005-10-28 | 2008-09-09 | University Of South Florida | Detection of polyketide synthetase gene expression in Karenia brevis |
| US7563577B2 (en) * | 2001-06-27 | 2009-07-21 | University Of South Florida | Materials and methods for detection of enterovirus and norovirus |
| US7700278B1 (en) * | 2003-01-08 | 2010-04-20 | University Of South Florida | Detection of red tide organisms by nucleic acid amplification |
-
2007
- 2007-04-16 US US11/735,618 patent/US7947441B2/en not_active Expired - Fee Related
- 2007-04-16 WO PCT/US2007/009235 patent/WO2007120869A2/en active Application Filing
-
2011
- 2011-04-18 US US13/089,146 patent/US20110223608A1/en not_active Abandoned
Patent Citations (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4851330A (en) * | 1983-01-10 | 1989-07-25 | Kohne David E | Method for detection, identification and quantitation of non-viral organisms |
| US5723597A (en) * | 1983-01-10 | 1998-03-03 | Gen-Probe Incorporated | Ribosomal nucleic acid probes for detecting organisms or groups of organisms |
| US5409818A (en) * | 1988-02-24 | 1995-04-25 | Cangene Corporation | Nucleic acid amplification process |
| US5334501A (en) * | 1989-07-11 | 1994-08-02 | Microprobe Corporation | Quantification of bacteria using a nucleic acid hybridization assay |
| US5695946A (en) * | 1991-02-14 | 1997-12-09 | Vicam, Lp | Assay method for detecting presence of bacteria |
| US5650290A (en) * | 1994-04-01 | 1997-07-22 | Hach Company | Method & Medium for use in detecting E. coli and total coliforms |
| US6001564A (en) * | 1994-09-12 | 1999-12-14 | Infectio Diagnostic, Inc. | Species specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
| US6583275B1 (en) * | 1997-07-02 | 2003-06-24 | Genome Therapeutics Corporation | Nucleic acid sequences and expression system relating to Enterococcus faecium for diagnostics and therapeutics |
| US6355421B1 (en) * | 1997-10-27 | 2002-03-12 | Boston Probes, Inc. | Methods, kits and compositions pertaining to PNA molecular beacons |
| US6821770B1 (en) * | 1999-05-03 | 2004-11-23 | Gen-Probe Incorporated | Polynucleotide matrix-based method of identifying microorganisms |
| US7563577B2 (en) * | 2001-06-27 | 2009-07-21 | University Of South Florida | Materials and methods for detection of enterovirus and norovirus |
| US7118870B2 (en) * | 2001-09-28 | 2006-10-10 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Detection of fecal contamination using nucleic acid molecules that recognize bacterial 16S rDNA sequences |
| US7700278B1 (en) * | 2003-01-08 | 2010-04-20 | University Of South Florida | Detection of red tide organisms by nucleic acid amplification |
| US7025112B1 (en) * | 2004-12-15 | 2006-04-11 | The United States Of America As Represented By The Secretary Of The Navy | Pretreatment processing of metal-matrix carbide power for mold casting of products |
| US7422857B2 (en) * | 2005-10-28 | 2008-09-09 | University Of South Florida | Detection of polyketide synthetase gene expression in Karenia brevis |
| US7888031B2 (en) * | 2005-10-28 | 2011-02-15 | University Of South Florida | Detection of polyketide synthetase gene expression in Karenia brevis |
Also Published As
| Publication number | Publication date |
|---|---|
| US7947441B2 (en) | 2011-05-24 |
| US20070243550A1 (en) | 2007-10-18 |
| WO2007120869A3 (en) | 2008-01-03 |
| WO2007120869A2 (en) | 2007-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Siefring et al. | Improved real-time PCR assays for the detection of fecal indicator bacteria in surface waters with different instrument and reagent systems | |
| Haugland et al. | Comparison of Enterococcus measurements in freshwater at two recreational beaches by quantitative polymerase chain reaction and membrane filter culture analysis | |
| Rajal et al. | Molecular quantitative analysis of human viruses in California stormwater | |
| Silva et al. | On the track for an efficient detection of Escherichia coli in water: A review on PCR-based methods | |
| Stults et al. | Application of the 5′ fluorogenic exonuclease assay (TaqMan) for quantitative ribosomal DNA and rRNA analysis in sediments | |
| Pitkänen | Review of Campylobacter spp. in drinking and environmental waters | |
| Hagedorn et al. | Microbial source tracking: methods, applications, and case studies | |
| Ishii et al. | Cladophora (Chlorophyta) spp. harbor human bacterial pathogens in nearshore water of Lake Michigan | |
| Gensberger et al. | Evaluation of quantitative PCR combined with PMA treatment for molecular assessment of microbial water quality | |
| EP2010671B1 (en) | Detection and quantification of faecal pollution in an environmental sample | |
| Baque et al. | A real-time RT-PCR method to detect viable Giardia lamblia cysts in environmental waters | |
| Santo Domingo et al. | Real-time PCR method to detect Enterococcus faecalis in water | |
| Johnston et al. | A real‐time qPCR assay for the detection of the nifH gene of Methanobrevibacter smithii, a potential indicator of sewage pollution | |
| KR20070105980A (en) | Quantitative Analysis of Microorganisms Targeting RNA | |
| Reza et al. | Rapid detection of coliforms in drinking water of Arak city using multiplex PCR method in comparison with the standard method of culture (Most Probably Number) | |
| Henry et al. | Environmental monitoring of waterborne Campylobacter: evaluation of the Australian standard and a hybrid extraction-free MPN-PCR method | |
| Satoh et al. | Simple and reliable enumeration of Escherichia coli concentrations in wastewater samples by measuring β-d-glucuronidase (GUS) activities via a microplate reader | |
| Hortelano et al. | Deep-amplicon sequencing (DAS) analysis to determine the presence of pathogenic Helicobacter species in wastewater reused for irrigation | |
| Maheux et al. | Abilities of the mCP agar method and CRENAME alpha toxin-specific real-time PCR assay to detect Clostridium perfringens spores in drinking water | |
| EP3827096A1 (en) | Method for assessing fecal pollution in water | |
| US7888031B2 (en) | Detection of polyketide synthetase gene expression in Karenia brevis | |
| US7947441B2 (en) | Molecular detection and quantification of Enterococci | |
| Gillespie | Current status of molecular microbiological techniques for the analysis of drinking water | |
| Fricker et al. | Use of the ISO 9308-1 procedure for the detection of E. coli in water utilizing two incubation temperatures and two confirmation procedures and comparison with defined substrate technology | |
| Pickup et al. | Monitoring bacterial pathogens in the environment: advantages of a multilayered approach |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |